Red blood transfusion in patients undergoing cardiac surgery by Noyez, L.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/152654
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
EDITORIAL COMMENT
Red blood transfusion in patients undergoing cardiac surgery
L. Noyez
Published online: 27 November 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
The use of allogeneic red blood cells (RBC) is commonplace
in cardiac surgery, with reported transfusion rates ranging
from 5 to 90 %. [1–4] Despite advantages, RBC transfusion
is associated with well-described adverse outcomes. [1–4]
Transfusion of RBCs is not only associated with an increased
perioperative mortality and morbidity, however; it also results
in a longer ICU stay, total hospital stay and increased costs. [2]
Even the long-term results are influenced by perioperative
RBC transfusions. Koch et al. found a significantly reduced
6-month and late survival in patients undergoing an isolated
CABGwith transfusion of RBCs. [1] Not only the question of
RBC transfusion, but also the number of units of transfused
RBCs and the method and duration of storage of RBCs is
important. [3, 4]
It is no surprise that several studies focus on blood conser-
vation methods and a more judicious use of RBCs, with as
prerequisite the identification of preoperative variables associ-
ated with an increased need for transfusion. [3, 4] Female
gender, impaired left ventricular function, low preoperative
haemoglobin, risk and complexity of the operation are the most
identified variables with an increased risk for RBC transfusion
[3, 4] However, even with the routine use of current blood
conservation methods, a proportion of patients undergoing
cardiac surgery continue to receive RBC transfusion and are
hence exposed to its associated risk [1–4]. There is, therefore,
an ongoing need to study further blood conservation methods.
In their recent study, [5] Haanschoten et al. focus on reducing
the immediate availability of RBCs in cardiac surgery. Since
March 2010, the No Elective Red Cells (NERC) program is
being used. The only change for their current study is that RBCs
are now not directly available in the operating theatre and, when
needed, the local blood bank can deliver the cross-matched
RBCs within 20 min. So, the aim of this new strategy is to
reduce the number of units of RBCs returned to the laboratory
and certainly the numbers of those units that can no longer be
used because of a reduced quality of the RBCs. This is of course
an interesting point in the whole discussion of blood conserva-
tion, mostly evaluated only on the percentage of patients without
RBC transfusion and /or the number of units transfused.
The authors show that in a selected group of patients it is
safe to perform cardiac surgery with the immediate availabil-
ity of RBCs in the operating theatre. [5] Eighty-one percent of
the patients did not receive any RBCs and the predictors for
the need of blood transfusion are confirming the results of
previous studies. [3, 4] However, some interesting points are
not discussed in this study.
& Since the start of the NERC program, what was the
percentage of RBCs returned to the blood bank and what
was the percentage of units that could no longer be used
because of reduced quality?
& It is emphasised that in all patients who need a blood
transfusion, blood was available within 20 min after or-
dering it. However, was this really so? What was the time
between ordering and delivering the blood in the operating
theatre?
& What happens in cases of catastrophic bleeding problems,
always possible even in the most simple cardiac
procedure?
These questions are essential before general conclusions
can be made about safety and the effectiveness of this new
strategy, no immediate availability of red blood cells, in the
NERC program.
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